<- Go Home
Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Market Cap
$85.3K
Volume
112.4K
Cash and Equivalents
$4.1M
EBITDA
-$9.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$7.47
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
0.02
Price / Earnings
-0.01
Price / Tangible Book Value
0.02
Enterprise Value
-$3.6M
Enterprise Value / EBITDA
0.39
Operating Income
-$9.5M
Return on Equity
113.96%
Return on Assets
-61.57
Cash and Short Term Investments
$4.1M
Debt
$451.0K
Equity
$3.4M
Revenue
N/A
Unlevered FCF
-$5.4M
Sector
Pharmaceuticals
Category
N/A